MedPath
HSA Approval

ULTRACARBON TABLET 250 mg

SIN05853P

ULTRACARBON TABLET 250 mg

ULTRACARBON TABLET 250 mg

May 20, 1991

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Licence HolderUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A07BA01

medicinal charcoal

Manufacturer Information

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Merck Healthcare KGaA

Active Ingredients

MEDICINAL CHARCOAL

250 mg

Activated charcoal

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.